GET DAILY SIGNALSBWXT Delivers Q3 Profit Beat with +26% EPS Growth
Key Takeaways
- Third quarter 2026 revenue rose 10% year over year to $953 million, but came in slightly below the consensus estimate of roughly $973 million.
- Adjusted earnings per share (EPS, or profit divided by shares outstanding) reached $1.26, beating the $1.19 consensus estimate by about 5.7% and rising 26% from a year ago.
- Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) grew 19% to $179.7 million, with an 18.9% margin that expanded 150 basis points.
- Free cash flow jumped 59% to $151 million, while total backlog climbed 15.6% to $8.56 billion.
- Management tightened full-year 2026 guidance to adjusted EPS of $4.72 to $4.77 and raised the low end of its free cash flow outlook to $350 million to $360 million.
- Despite the bottom-line beat, shares slipped roughly 2.7% in after-hours trading as investors weighed the top-line shortfall.
- For more on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the additional pages linked here for deeper analysis.
- Explore Trending AI Robots to see how AI-driven trading strategies are approaching opportunities across the market.
Why This Quarter Matters for BWXT
BWX Technologies (BWXT) sits at the intersection of national security and the growing commercial nuclear sector. It provides nuclear components and fuel for U.S. Navy programs while also serving civilian reactor operators, nuclear medicine, and microreactor developers. With demand rising in both government and commercial areas, each earnings report shows how quickly that demand turns into revenue and backlog. I’m watching margin performance closely because the company has been investing in capacity ahead of expected order growth. The third quarter tested whether profitability gains could hold even when top-line results came in a bit light.
Breaking Down the Reported Figures
In the third quarter of 2026, BWXT posted revenue of $953 million, up 10% year over year with 7% organic growth. That figure missed the consensus of about $973 million. Government Operations revenue rose 4% to $639 million, helped by Special Materials and Advanced Nuclear work, while Commercial Operations revenue increased 25% to $314 million following the Precision Components Group acquisition. I also checked this using Tickeron’s AI Screener to compare the results against industry peers.
Adjusted EPS reached $1.26, above the $1.19 estimate and up 26% from $1.00 a year earlier. Adjusted EBITDA grew 19% to $179.7 million, beating the $167.5 million consensus and delivering an 18.9% margin. Free cash flow climbed to $151 million from $95 million in the prior-year quarter. Management kept full-year revenue guidance near $3.8 billion and adjusted EPS between $4.72 and $4.77, while lifting the lower end of free cash flow expectations to $350 million to $360 million.
How the Market Responded
Shares of BWXT fell about 2.7% in after-hours trading to near $127 even with the earnings beat and margin expansion. The reaction highlights how high expectations can overshadow solid bottom-line results. The stock has been trading near the lower end of its 52-week range of $123.05 to $241.82, reflecting cautious sentiment where even strong cash generation leaves little room for a revenue shortfall. Investors seemed to appreciate the guidance consistency but focused on the top-line miss heading into the next session.
Looking Ahead at Key Drivers
Management offered a preliminary 2027 outlook that calls for high single-digit to low double-digit growth in adjusted EBITDA and adjusted EPS, supported by core businesses and expanding Special Materials contributions. For the rest of 2026 the company still expects revenue near $3.8 billion, adjusted EBITDA around $667 million, and adjusted EPS of $4.72 to $4.77.
Several items will influence the coming quarters. Investors will want to see the growing bid pipeline convert into firm contracts, especially in naval propulsion and advanced nuclear programs such as the BANR microreactor recently chosen for U.S. Army and Canadian projects. Capacity expansions in Cambridge, Ontario, and potential new U.S. commercial facilities remain important. The Precision Components Group integration and planned medical business divestiture could also affect segment performance. Capital allocation stays disciplined following the recent investment-grade rating from Fitch, with priorities centered on organic growth, selective acquisitions, and shareholder returns.
Refining My Research Process
In my own work I often turn to Tickeron’s AI Screener to quickly filter ideas by fundamentals, technical patterns, and AI signals. It helps me compare BWXT against other names in the sector and spot setups worth deeper review without spending hours on manual screens. The tool has become a regular part of how I organize research around earnings movers and emerging opportunities.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BWXT in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 22, 2026
BWXT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 37 cases where BWXT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BWXT's RSI Indicator exited the oversold zone, 13 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for BWXT just turned positive on October 27, 2026. Looking at past instances where BWXT's MACD turned positive, the stock continued to rise in 30 of 46 cases over the following month. The odds of a continued upward trend are 65%.
Following a +2.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWXT advanced for three days, in 226 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 65 cases where BWXT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BWXT as a result. In 46 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWXT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
The Aroon Indicator for BWXT entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. BWXT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.974) is normal, around the industry mean (5.060). P/E Ratio (33.773) is within average values for comparable stocks, (17.792). BWXT's Projected Growth (PEG Ratio) (27.780) is very high in comparison to the industry average of (3.110). Dividend Yield (0.008) settles around the average of (0.058) among similar stocks. P/S Ratio (3.811) is also within normal values, averaging (18.367).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of components and services to nuclear power industry
Industry AerospaceDefense
Advertisement